LSE:SN. (Smith & Nephew plc)
About SN.
Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
Smith & Nephew plc (LSE: SN.) Latest News
Investing Articles
Forecast earnings growth of 17% a year but down 12%, is now the time for me to buy this heavyweight FTSE stock?
Investing Articles
Up 10% in 2025, can this FTSE 100 recovery share keep soaring?
Investing Articles
Has the Smith & Nephew share price finally turned the corner?
Investing Articles
3 steps to start investing with under £300
Investing Articles
3 FTSE 100 stocks that could be takeover targets in 2025
Value Shares
An insider at this FTSE 100 company just bought £700k worth of stock
Investing Articles
Down 21% and with key investors pushing for a break-up of this FTSE firm, is now the time for me to buy?
Dividend Shares
This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?
Investing Articles
Down 21%, is the Smith & Nephew share price too cheap to ignore?
Investing Articles
After crashing 13% in a day, is Smith & Nephew now a ‘no-brainer’ value stock?
Investing Articles
As Smith & Nephew shares tumble, is it time to buy?